TP53 and neoplasm: Prominent reduction in TP53 mutated compared with wild type tumours was seen in multiple cancers for this lncRNA, with the strongest association in the BRCA luminal B subtype (P=4.1e-21, Wilcoxon rank sum test; Fig. 4e).